Alder BioPharmaceuticals approaches rare status for a Seattle biotech

Leading up to the anticipated February 2020 FDA approval date, Alder plans to double the size of its workforce.

Previous Barnwell Industries Inc. sees net loss, exec pay cuts continue
Next Hear ye! Hear ye! Go inside Medieval Times Scottsdale

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *